D1 Purchase description.pdf
PDF 132 KB Posted
- Solicitation number
- 75N95024Q00497
About this file
This document is a combined synopsis/solicitation for a commercial item, specifically a data sharing platform for the Center for Alzheimer's Disease and Related Dementias (CARD). The National Institute on Drug Abuse (NIDA), on behalf of the National Center for Advancing Translational Sciences (NCATS), intends to negotiate and award a firm fixed-price contract without full and open competition to Verily Life Sciences LLC for the Verily Workbench License Data Sharing Platform.
The key requirements include a platform that provides implementation services, a workbench license for external collaboration and data delivery, access to the Verily-managed GCP-backed multi-tenant Verily Workbench, unlimited external use for CARD data, support for external use cases and collaborator onboarding, ongoing product updates, internal publication support, and data governance controls. The anticipated award date is September 20, 2024, with a 1-month delivery after receipt of order. The period of performance includes a 1-year base and two 12-month option years, with a 1-year manufacturer warranty. Responses are due by 9 a.m. Eastern Time on August 28, 2024, and must be submitted electronically.
View the file
Other files
| File | Type | Posted |
|---|---|---|
| CSS NONCOMPETITIVE (NCATS).docx | DOCX document | |
| D5 FAR 52.212-5 (Jun 2023) FILLABLE 06-02-2023.pdf | ||
| D4 FAR 52.212-4_Addendum_Supplier_Licenses.pdf | ||
| D6 Invoicing Instructions.pdf | ||
| D2 FAR 52.204-24 (Nov 2021).pdf | ||
| D3 FAR 52.204-26 (Oct 2020).pdf |
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Version 11-30-2016-1 FAR Part 11—Describing Agency Needs
PURCHASE DESCRIPTION
1. Statement of Need and Purpose: This acquisition is necessary to provide data sharing platform to the Center for Alzheimer’s Disease and Related Dementias (CARD) to facilitate data sharing, analysis, and continuity of ongoing research projects with external collaborators.
2. Background Information and Objective: imaging technology improves to capture
CARD is collaborating with many world-wide research institutions on projects related to
Alzheimer’s Disease and Related Dementias. There is still much to learn about genetic risk factors in ADRD and the path to further understanding requires working collaboratively and openly sharing data, processes, and results. This resource will substantially accelerate the pace of mechanistic discovery regarding how ADRD mutations cause disease.
3. Generic Name of Product: Data sharing platform
4. Purchase Description:
Line Item Description Cat number
Verily Workbench License Fee for External Collaboration and Data Delivery Use NA
5. Salient characteristics All deliverables required under this contract shall be packaged, marked and shipped in accordance with Government specifications. At a minimum, all deliverables shall be marked with the contract number and Contractor name. The
Contractor shall guarantee that all required materials shall be delivered in immediate usable and acceptable condition.
Vendor must be able to provide these specifications:
Platform must provide implementation services including platform deployment, data integration, and initial user onboarding.
Platform must provide workbench license for external collaboration and data delivery use.
Version 11-30-2016-1 FAR Part 11—Describing Agency Needs
Platform must provide access to Verily-managed GCP-backed multi-tenant Verily
Workbench.
Platform must provide unlimited external use for CARD data only.
Platform must provide support for external use cases and collaboration needs, including external collaborator onboarding.
Platform must provide ongoing product updates for external and internal use.
Platform must provide internal publication support, and internal research initiatives.
Platform must provide use with internal CARD data and other data CARD is authorized to access
Platform must provide a library of multimodal data on neurodegenerative disease
Platform must provide data governance controls, including the ability for data owners to define multiple data collections, to define auto-enforced collection-specific policies, and to track access to data and data derivatives.
Platform must provide scalable biomedical research applications, including built-in tools and the ability to easily configure custom tools.
Platform must provide infrastructure flexibility, including support for multiple control & analysis planes across multiple cloud platforms.
6. Quantity:
7. Delivery Date: Delivery date of 1 month after receipt of completed purchase order
8. Period of Performance: One Year Base. Two 12-Month Option Years. Manufacturer warranty for one calendar year beginning date of receipt.
9. Option(s): Two (2) 12-Month Option Years
File details come from the government source that posted it. Updated .